Skip to main content

Advertisement

SpringerLink
Log in

Long-Term Survival in an Esophageal Cancer Patient with Multiple Recurrences

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.

    Article  Google Scholar 

  2. Rustgi AK, El-serag HB. Esophageal carcinoma. N Engl J Med. 2014;371:2499–509.

    Google Scholar 

  3. Parry K, Visser E, van Rossum PS, Mohammad NH, Ruurda JP, van Hillegersberg R. Prognosis and treatment after diagnosis of recurrent esophageal carcinoma following esophagectomy with curative intent. Ann Surg Oncol. 2015;22(Suppl 3):S1292–300.

    Article  Google Scholar 

  4. Abate E, DeMeester SR, Zehetner J, Oezcelik A, Ayazi S, Costales J, et al. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg. 2010;210:428–35.

    Article  Google Scholar 

  5. Polee MB, Hop WC, Kok TC, Eskens FA, van der Burg M, Splinter TA, et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer. 2003;89(11):2045–50.

    Article  CAS  Google Scholar 

  6. Vignoud J, Visset J, Paineau J, et al. Preoperative chemotherapy in squamous cell carcinoma of the esophagus: clinical and pathological analysis, 48 cases. Ann Oncol. 1990;1:45.

    Article  Google Scholar 

  7. Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, et al. Randomized phase II study of cisplatin and 5-FU versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer. 1997;33:1216–20.

    Article  CAS  Google Scholar 

  8. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group. J Clin Oncol. 2006;24:4991.

    Article  Google Scholar 

  9. Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol. 1997;15:261–7.

    Article  CAS  Google Scholar 

  10. Homs MY, v. d. Gaast A, Siersema PD, Steyerberg EW, Kuipers EJ. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction. Cochrane Database Syst Rev. 2006;18(4):CD004063.

    Google Scholar 

  11. Sumi H, Ohtsu A, Boku N, Muto M, Nagashima F, Hosokawa K, et al. A case of inoperable esophageal carcinoma with hepatic and nodal metastases which showed a long-term survival after chemoradiotherapy including nedaplatin. Jpn J Clin Oncol. 2000;30(9):406–9.

    Article  CAS  Google Scholar 

  12. Saletti P, Ghielmini M, Martinoli S, Goldhirsch A. Sustained complete remission of metastatic oesophageal adenocarcinoma using long-term therapy with 5-fluorouracil. Ann Oncol. 2004;15(7):1145–6.

    Article  CAS  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Sector-5, Rohini, Delhi, India

    Rakshya Shrestha, Pankaj Goyal, Chaturbhuj Agarwal & Dinesh Chandra Doval

  2. Department of Research, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India

    Rupal Tripathi

  3. Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India

    Manoj Gupta

  4. Department of Pathology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India

    Anurag Mehta

Authors
  1. Rakshya Shrestha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rupal Tripathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pankaj Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chaturbhuj Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manoj Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anurag Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dinesh Chandra Doval
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dinesh Chandra Doval.

Ethics declarations

The Institutional Review Board (Ethics committee) of Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India, approved the conduct of case report and granted a waiver from the consenting process vide letter no. RGCIRC/IRB/367/2019.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shrestha, R., Tripathi, R., Goyal, P. et al. Long-Term Survival in an Esophageal Cancer Patient with Multiple Recurrences. J Gastrointest Canc 51, 695–697 (2020). https://doi.org/10.1007/s12029-020-00366-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-020-00366-3

Search

Navigation